Cargando…
TGF-β Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer
Genetic alterations affecting transforming growth Factor–β (TGF-β) signaling are exceptionally common in diseases and cancers of the gastrointestinal system. As a regulator of tissue renewal, TGF-β signaling and the downstream SMAD-dependent transcriptional events play complex roles in the transitio...
Autores principales: | Gough, Nancy R., Xiang, Xiyan, Mishra, Lopa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841117/ https://www.ncbi.nlm.nih.gov/pubmed/33940008 http://dx.doi.org/10.1053/j.gastro.2021.04.064 |
Ejemplares similares
-
The role of TGF-β/SMAD4 signaling in cancer
por: Zhao, Ming, et al.
Publicado: (2018) -
TGF-β Signaling in Neuronal Stem Cells
por: Yun, Chohee, et al.
Publicado: (2008) -
Alterations in TGF-β signaling leads to high HMGA2 levels potentially through modulation of PJA1/SMAD3 in HCC cells
por: Ohshiro, Kazufumi, et al.
Publicado: (2020) -
TGF-β Signaling in Gastrointestinal Cancers: Progress in Basic and Clinical Research
por: Yokobori, Takehiko, et al.
Publicado: (2017) -
TGF‐β signaling in liver metastasis
por: Marvin, Dieuwke L, et al.
Publicado: (2020)